PMEPA1 promotes androgen receptor-negative prostate cell proliferation through suppressing the Smad3/4-c-Myc-p21Cip1 signaling pathway

Journal of Pathology

Volumn 223, Issue 5, 2011, Pages 683-694

  Liu, Rong ^a   Zhou, Zhongmei ^a,b   Huang, Jian ^c   Chen, Ceshi ^a,b  

^a ALBANY MEDICAL COLLEGE   (United States)

^b KUNMING INSTITUTE OF ZOOLOGY   (China)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

c Myc; p21; PMEPA1; Prostate cancer; Smad3

Indexed keywords

ANDROGEN RECEPTOR; MEMBRANE PROTEIN; MYC PROTEIN; PMEPA1 PROTEIN; PROTEIN P21; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE FUNCTION; GENE INDUCTION; GENE OVEREXPRESSION; GENE TRANSLOCATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MALE; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT; UPREGULATION;

ANIMALS; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; MALE; MEMBRANE PROTEINS; MICE; MICE, SCID; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTORS, ANDROGEN; SIGNAL TRANSDUCTION; SMAD3 PROTEIN; SMAD4 PROTEIN;

EID: 79952554055     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2834     Document Type: Article

References (29)

1. Ishkanian AS, Mallof CA, Ho J, et al. High-resolution array CGH identifies novel regions of genomic alteration in intermediate-risk prostate cancer. Prostate 2009; 69: 1091-1100.
2. Tanner MM, Tirkkonen M, Kallioniemi A, et al. Increased copy number at 20q13 in breast cancer: defining the critical region and exclusion of candidate genes. Cancer Res 1994; 54: 4257-4260. (Pubitemid 24273128)
3. Hidaka S, Yasutake T, Takeshita H, et al. Differences in 20q13.2 copy number between colorectal cancers with and without liver metastasis. Clin Cancer Res 2000; 6: 2712-2717. (Pubitemid 30482109)
4. Xu LL, Shanmugam N, Segawa T, et al. A novel androgen-regulated gene, PMEPA1, located on chromosome 20q13 exhibits high level expression in prostate. Genomics 2000; 66: 257-263. (Pubitemid 30481772)
5. Giannini G, Ambrosini MI, Di Marcotullio L, et al. EGF- and cell-cycle-regulated STAG1/PMEPA1/ERG1.2 belongs to a conserved gene family and is overexpressed and amplified in breast and ovarian cancer. Mol Carcinog 2003; 38: 188-200. (Pubitemid 37523711)
6. Hirokawa YS, Takagi A, Uchida K, et al. High level expression of STAG1/PMEPA1 in an androgen-independent prostate cancer PC3 subclone. Cell Mol Biol Lett 2007; 12: 370-377.
7. Brunschwig EB, Wilson K, Mack D, et al. PMEPA1, a transforming growth factor-beta-induced marker of terminal colonocyte differentiation whose expression is maintained in primary and metastatic colon cancer. Cancer Res 2003; 63: 1568-1575. (Pubitemid 36373645)
8. Reichling T, Goss KH, Carson DJ, et al. Transcriptional profiles of intestinal tumors in Apc(Min) mice are unique from those of embryonic intestine and identify novel gene targets dysregulated in human colorectal tumors. Cancer Res 2005; 65: 166-176. (Pubitemid 40070807)
9. Rae FK, Hooper JD, Nicol DL, et al. Characterization of a novel gene, STAG1/PMEPA1, upregulated in renal cell carcinoma and other solid tumors. Mol Carcinog 2001; 32: 44-53.
10. Itoh S, Thorikay M, Kowanetz M, et al. Elucidation of Smad requirement in transforming growth factor-beta type I receptor-induced responses. J Biol Chem 2003; 278: 3751-3761. (Pubitemid 36801101)
11. Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003; 113: 685-700. (Pubitemid 36724933)
12. Chen CR, Kang Y, Siegel PM, et al. E2F4/5 and p107 as Smad cofactors linking the TGFbeta receptor to c-myc repression. Cell 2002; 110: 19-32. (Pubitemid 34874603)
13. Polyak K, Kato JY, Solomon MJ, et al. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev 1994; 8: 9-22.
14. Levy L, Hill CS. Smad4 dependency defines two classes of transforming growth factor {beta} (TGF-{beta}) target genes and distinguishes TGF-{beta}-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses. Mol Cell Biol 2005; 25: 8108-8125. (Pubitemid 41263004)
15. Watanabe Y, Itoh S, Goto T, et al. TMEPAI, a transmembrane TGF-beta-inducible protein, sequesters Smad proteins from active participation in TGF-beta signaling. Mol Cell 2010; 37: 123-134.
16. Singha PK, Yeh IT, Venkatachalam MA, et al. Transforming growth factor-{beta} (TGF-{beta})-inducible gene TMEPAI converts TGF-{beta} from a tumor suppressor to a tumor promoter in breast cancer. Cancer Res 2010; 70: 6377-6383.
17. Anazawa Y, Arakawa H, Nakagawa H, et al. Identification of STAG1 as a key mediator of a p53-dependent apoptotic pathway. Oncogene 2004; 23: 7621-7627. (Pubitemid 39424920)
18. Xu LL, Shi Y, Petrovics G, et al. PMEPA1, an androgen-regulated NEDD4-binding protein, exhibits cell growth inhibitory function and decreased expression during prostate cancer progression. Cancer Res 2003; 63: 4299-4304. (Pubitemid 36950993)
19. Li H, Xu LL, Masuda K, et al. A feedback loop between the androgen receptor and a NEDD4-binding protein, PMEPA1, in prostate cancer cells. J Biol Chem 2008; 283: 28988-28995.
20. Litvinov IV, Vander Griend DJ, Xu Y, et al. Low-calcium serum-free defined medium selects for growth of normal prostatic epithelial stem cells. Cancer Res 2006; 66: 8598-8607. (Pubitemid 44449174)
21. Altuwaijri S, Wu CC, Niu YJ, et al. Expression of human AR cDNA driven by its own promoter results in mild promotion, but not suppression, of growth in human prostate cancer PC-3 cells. Asian J Androl 2007; 9: 181-188. (Pubitemid 46416578)
22. Mohsin SK, Weiss H, Havighurst T, et al. Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: a validation study. Mod Pathol 2004; 17: 1545-1554. (Pubitemid 39627082)
23. Alexandrow MG, Moses HL. Transforming growth factor beta and cell cycle regulation. Cancer Res 1995; 55: 1452-1457.
24. Nupponen NN, Kakkola L, Koivisto P, et al. Genetic alterations in hormone-refractory recurrent prostate carcinomas. Am J Pathol 1998; 153: 141-148. (Pubitemid 28317516)
25. Kaltz-Wittmer C, Klenk U, Glaessgen A, et al. FISH analysis of gene aberrations (MYC, CCND1, ERBB2, RB, and AR) in advanced prostatic carcinomas before and after androgen deprivation therapy. Lab Invest 2000; 80: 1455-1464.
26. Bernard D, Pourtier-Manzanedo A, Gil J, et al. Myc confers androgen-independent prostate cancer cell growth. J Clin Invest 2003; 112: 1724-1731. (Pubitemid 38063730)
27. Chen C, Sun X, Guo P, et al. Human Kruppel-like factor 5 is a target of the E3 ubiquitin ligase WWP1 for proteolysis in epithelial cells. J Biol Chem 2005; 280: 41553-41561. (Pubitemid 41832217)
28. Fan W, Jin S, Tong T, et al. BRCA1 regulates GADD45 through its interactions with the OCT-1 and CAAT motifs. J Biol Chem 2002; 277: 8061-8067. (Pubitemid 34968259)
29. Chen C, Benjamin MS, Sun X, et al. KLF5 promotes cell proliferation and tumorigenesis through gene regulation in the TSU-Pr1 human bladder cancer cell line. Int J Cancer 2006; 118: 1346-1355.